Ngā hua rapu - Midori Awazu
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
-
2
-
3
-
4
Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes mā Kei-ichi Ozaki, Midori Awazu, Mayuko Tamiya, Yuka W. Iwasaki, Aya Harada, Satomi Kugisaki, Susumu Tanimura, Michiaki Kohno
I whakaputaina 2016Artigo -
5
Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat. mā Norishige Yoshikawa, Hiroshi Ito, Tadasu Sakai, Yasuo Takekoshi, Masataka Honda, Midori Awazu, Katsumi Ito, Kikuo Iitaka, Yasushi Koitabashi, Yuichi Yamaoka, Kimiko Nakagawa, Hajime Nakamura, S Matsuyama, Yoshiki Seino, Nobuaki Takeda, Shinzaburou Hattori, Makoto Ninomiya
I whakaputaina 1999Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Endocrinology
Internal medicine
Medicine
Chemistry
Diabetes mellitus
Kidney
Biology
Cell biology
MAPK/ERK pathway
3T3-L1
Adipocyte
Adipokine
Adipose tissue
Adverse effect
Albuminuria
Angiotensin II
Angiotensin II receptor type 1
Angiotensin receptor
Azathioprine
Candesartan
Dephosphorylation
Diabetic nephropathy
Dipyridamole
Disease
Gastroenterology
Insulin resistance
Kinase
Lipolysis
MEK inhibitor
Mesangial cell